Abstract | AIM: MATERIAL AND METHODS: 30 patients (mean age 51.4 years) with a definite primary LBP took structum in a dose 1 g/day for 24 weeks. The diagnosis was made according to WHO recommendations (2000). The response was assessed with uniform international questionnaires and visual analogue scale. RESULTS: The treatment reduced pain syndrome and improved spinal function in 73.3% patients with LBP studied. CONCLUSION: It would be valid to include long-acting chondroprotective drugs in the program of LBP in spinal osteochondrosis.
|
Authors | N A Shostak, A V Aksenova, N G Pravdiuk, D A Shemetov, D G Soldatov |
Journal | Terapevticheskii arkhiv
(Ter Arkh)
Vol. 74
Issue 8
Pg. 67-9
( 2002)
ISSN: 0040-3660 [Print] Russia (Federation) |
Vernacular Title | Voli v nizhneĭ chasti spiny pri osteokhondroze pozvonochnika: opyt primeneniia khondroprotektivnogo preparata. |
PMID | 12360602
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Chondroitin Sulfates
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Osteochondritis
(drug therapy, physiopathology)
- Pain
(drug therapy, physiopathology)
- Spinal Diseases
(drug therapy, physiopathology)
- Surveys and Questionnaires
- Treatment Outcome
|